It is not entirely clear if all melanoma LMD tumors will exhibit upregulation of SERPINA3, or whether past treatment history may have affected our results as the majority of progressing late-stage melanoma patients are heavily pre-treated and we did not have enough patients on this study to draw any treatment-related conclusions. This evidence concerns the gene SERPINA3 and melanoma.